Acadian Asset Management
IMGN

Acadian Asset Management’s Immunogen Inc IMGN Stock Holding History

Acadian Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,815
Closed -$71K – 2090
2021
Q2 		$71K Sell
10,815
-914
-8% -$6.38K ﹤0.01% 1726
2021
Q1 		$95K Buy
+11,729
New +$95.8K ﹤0.01% 1686
2020
Q4 		– Sell
-28,351
Closed -$102K – 2386
2020
Q3 		$102K Sell
28,351
-141,585
-83% -$572K ﹤0.01% 1656
2020
Q2 		$781K Buy
169,936
+92,843
+120% +$395K ﹤0.01% 1044
2020
Q1 		$263K Sell
77,093
-100,762
-57% -$441K ﹤0.01% 1131
2019
Q4 		$908K Sell
177,855
-11,642
-6% -$39.5K ﹤0.01% 905
2019
Q3 		$459K Buy
+189,497
New +$503K ﹤0.01% 1104
2017
Q3 		– Sell
-4,296
Closed -$31K – 1568
2017
Q2 		$31K Sell
4,296
-26,031
-86% -$119K ﹤0.01% 1201
2017
Q1 		$117K Buy
+30,327
New +$88.5K ﹤0.01% 1118
2016
Q3 		– Sell
-24,637
Closed -$76K – 1582
2016
Q2 		$76K Buy
+24,637
New +$154K ﹤0.01% 1070

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Acadian Asset Management's IMGN Position: Q3 2021 in Review

Acadian Asset Management sold out of Immunogen Inc (IMGN) in Q3 2021, closing a stake of 10,815 shares — an estimated $71K sold.

Acadian Asset Management first reported a position in IMGN in Q2 2016 and held it in 10 quarters. The position peaked at $908K in Q4 2019. 217 funds tracked by Wall St. Rank hold IMGN as of Q3 2021.

  • Acadian Asset Management reported no remaining Immunogen Inc position as of Q3 2021 after selling out during the quarter.
  • Acadian Asset Management sold 10,815 Immunogen Inc shares in Q3 2021, an estimated $71K.
  • Acadian Asset Management first reported a position in Immunogen Inc in Q2 2016 and held it in 10 quarters.
  • Acadian Asset Management's Immunogen Inc position peaked at $908K in Q4 2019.
  • 217 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2021.

Based on Acadian Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.